Head-to-head · Value Score
CoreAge Rx vs RENN Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, RENN Health a 69. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameRENN Health
#256 · Grade C · Watch List
Est. first month
As low as $149/month as published (a floor with no billing period stated; no month-to-month rate appears anywhere)
Save ~89% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 69 — an est. $99/mo first month, with no teaser step-up baked in. RENN Health isn't out of it: Readers who want a named medical group and named prescribers behind the treatment and will call for a price, since the site never gives one that can be relied on.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | RENN Health |
|---|---|---|
| Value Score | 93 (A+) | 69 (C) |
| Est. first month | $99/mo | As low as $149/month as published (a floor with no billing period stated; no month-to-month rate appears anywhere) |
| Save vs brand-name | ~89% | ~89% |
| Semaglutide | $99/mo | As low as $149/month as published (a floor with no billing period stated; no month-to-month rate appears anywhere) |
| Tirzepatide | $149/mo | As low as $199/month as published (the same floor shape, with no billing period and no month-to-month rate) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
RENN Health
Semaglutide advertised at "as low as $149 a month" and tirzepatide at $199, with no billing period attached to either, no standing rate published anywhere, and a memberships page that still says Placeholder where the prices belong.
Why it's a deal
- Six dispensing pharmacies are named, each with a website and a phone number — the widest pharmacy naming in this batch
- The medical group is named and two prescribing physicians are named with identifiers that can be checked against a federal registry, which almost nothing else in this batch offers
- Coverage is answered directly in the questions as all fifty states, with the ordinary caveat that availability varies by provider licensure
- Both GLP-1s have their own product pages with dose and mechanism explained rather than being sold as one undifferentiated program
- A phone number and an email address are published, and a dietitian consultation and the telehealth visit are both stated as costing nothing
The fine print
- Every published figure is a floor with no billing period attached. "As low as $149/month" appears four times on the homepage and again on the product page, and nothing on the site says what a standing month costs
- The memberships page — the one place a shopper would go to resolve it — is unfinished: a first and a third tier with no second, and the word Placeholder printed where each price belongs
- A twenty-two-screen walk of the public signup reached the final attestation screen without one dollar figure being shown, so the price is not reachable before agreeing to terms
- No cancellation policy, no refund policy and no auto-renewal terms exist anywhere on the site, on a product sold with three- and six-month bundles. A census of eleven pages found none of those words at all
- The word compounded never appears on the marketing site, so the single most important fact about what is being sold is not disclosed on any page a reader will see
- No legal entity, no company suffix and no street address is published — a census of eleven pages found none
- Two governing-law clauses sit in one terms document, and the privacy policy is boilerplate from a rental and hospitality template describing reservation systems
- Belmar Pharma Solutions, one of the six pharmacies named, was issued an FDA warning letter on March 31, 2023 addressed to "Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy" of Lakewood, Colorado. The letter is against that pharmacy, not against RENN Health, and it is recorded here because the site names the company that may compound the prescription: fda.gov publishes it in its warning-letter database
- An oral tablet form of each molecule exists in the signup's own catalog and appears on no page of the marketing site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to RENN Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.